Short course treatment of pulmonary tuberculosis patients suffering from multiple drug resistance. The current situation and future perspectives
Autor: | A. E. Russkikh, D. M. Kutuzova, O. V. Lovacheva, A. G. Samoylova, I. A. Vasilyeva |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
linezolid short course treatment regimens delamanid Clofazimine Diseases of the respiratory system chemistry.chemical_compound Moxifloxacin Internal medicine clofazimine medicine multiple drug resistant tuberculosis bedaquiline RC705-779 business.industry Treatment regimen Drug resistant tuberculosis General Medicine chemistry bpal regimen treatment of tuberculosis Pretomanid Linezolid pretomanid moxifloxacin Delamanid Bedaquiline business medicine.drug |
Zdroj: | Tuberkulez i Bolezni Lëgkih, Vol 98, Iss 12, Pp 57-66 (2021) |
ISSN: | 2542-1506 2075-1230 |
DOI: | 10.21292/2075-1230-2020-98-12-57-66 |
Popis: | The article presents a review of 70 publications. It describes relevant data on drugs, timing, indications, efficacy, and safety of short-term treatment regimens for multiple drug resistant tuberculosis. |
Databáze: | OpenAIRE |
Externí odkaz: |